Bufexamac and diclofenac: frequency of contact sensitization and absence of cross-reactions.
Barbaud
A
A
Dermatology Department, Fournier Hospital, Nancy, France.
Tréchot
P
P
Aublet-Cuvelier
A
A
Reichert-Penetrat
S
S
Schmutz
J L
JL
D000287:Administration, Topical; D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D002019:Bufexamac / Q000009:adverse effects*; D003429:Cross Reactions; D017449:Dermatitis, Allergic Contact / Q000209:etiology*; D004008:Diclofenac / Q000009:adverse effects*; D006801:Humans; D007428:Intradermal Tests; D010328:Patch Tests
D000893:Anti-Inflammatory Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D004008:Diclofenac; D002019:Bufexamac